Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential


TSX:EDT - Post by User

Post by SouthernTierTomon Oct 30, 2021 9:21am
224 Views
Post# 34067517

Lets leave the "miracles" to the science shall oui?

Lets leave the "miracles" to the science shall oui?"you know Claudio... you have the PMX available to you"

* Like Canada, his current employer, they have had it available to them along with the EAA ( the "theranostic" approach, since 2003..check my math MM, but that is like 18 years! )

Once we end whatever bizarro arrangement we have for focussing on the "rental" of SAMI units, perhaps the Dialco ( wholly-owned subsidiary ) of Spectral will start to produce some small "revenue miracles"  The handling of "Dialco" feels much like the acceptance of the 6.6 M CAD from Baxter only to be hacked into 108 revenue crumbs over 9 years. "SMART" especially when you have an undisclosed 1.7M CAD "leagacy fee" to apply in one fell swoop against the quarter and proceed to do a lousy financing with your former employer after you cost the company ~ 275K CAD for "messing up the first attempt" to "do a shareholder/ I mean financing"

The DIMI miracle is just in the "slow cooker", see we received FDA approval for this asset in August 2020.  The state-of-the-art home dialysis unit is already FDA  APPROVED.  Now, some 15 months later we continue to scour the US for 35 willing participants to use the "pending miracle maker"  In hindsight, this miracle is still in the "early stages" ( right Mr. Analsyt ; - )  )?  Especially when you consider there are well over 35 MILLION Canadiens that over the last 18 years don't see to have been able to try the EAA or the PMX, despite FULL approval.

I wouldn't question a THING that is being executed by management, the same people that made Hemosol go to $27/share CAD are deeply rooted in this tale.  There is a difference though, the deep thinkers here aren't so anxious to "tell ALL", but rather keep a strangely loe profile and gather as much paper as possible at the lowest possible price.  Interesting.

For now let's circle back to this TIGGER trial, that's seems to currently lack the "energy / bounce" the name might imply.  In late July 2021, the company delcared 19 patients enrolled.  Fear not though, we had a "rally cap" moment with our knew CMO organizing the the "Down-Under" event in Australia to loop in another friend and "RE-BOOT" the TIGGER.  Hmmm, so this weak in our Exec's ( I don't like using his name, I think they installed the former excecutive of a NOW 2 CENT Canadien pot company to do EXACTLY what he has done ) powerlesspoint presentation he/oui advertise 23 patients enrolled.  So after the "RE-BOOT" and all the games ( including Deb's Let's play Jeopardy ) we enroll 4 patients at 11 to 12 actively recruiting, PMX experienced Hospitals here in the US?  An average of 1.33333/patients per month?  This > 5 years after the FAILED phase 3 trial ( the one providing > 40% of the data for the FDA's current phase 4 confirmatory trial ) AND after the FDA stamps "Extended Use" approval on the device guided by a 2003 FDA approved diagnostic AND a 2018  FDA SAMI delivery vehicle ( can you rent these at select Stephenson locations? )  

If I were running this program, I would remove the person that publically called the company a FRAUD ( Stocktree ) and the board "Corrupt" ( Ooops Stocktree again ) from the Canadien Stockhouse Network.  It doesn't mesh well with the rest of the activity.  Bear in mind, that on the morning of October 3rd 2016, Natalie from Reuters had her interview completed with a "company official" and her story fully written and edited by 9am,  The news came out at 8am.  Within hours of this production, both our 70 cent financing partners were declaring 4 and 5 cent targets on Spectral and CNBNN up in Canada was blasting out the "UPDATES".  On that very day, October 3rd 2016, our pals ( The Beech Boys ) using IDs like "Stocktree" posted every few minutes..ALL DAY LONG.  Stocktree alone posted ~ 20 times on October 3rd 2016 as he appeared to be in full "burial mode" of his prized asset.

Something is VERY wrong here isn't it?  I just wish insiders would start to SELL to "confirm" said "VERY WRONG" ...instead they continue to want and take more at the expense of others and their experience with their "investment" ---- "SHAME on Greeed, SHAME on you"

Next I will provide the BEST POST I have ever seen.  a declaration on the morning of October 3rd 2016 from a favorite old poster of mine that inspired me to join the common shareholder information board AND told us all that..."really ONLY 176 patients of the 450  advertised mattered" and quized the company on just why they decided to "top-line report all 450 patients" Hmmm how "insightful of this poster" ...wait for it... ; - )

T
<< Previous
Bullboard Posts
Next >>